How the Legionella Effector SidL Modifies 3-Phosphoglycerate via Adenylyltransferase Activity
- Get link
- X
- Other Apps
Highlights
- •SidL is an actin-dependent adenylyltransferase that targets host glycolysis
- •SidL adenylates 3PG to produce 2-AMP-3PG
- •Expression of SidL in human cells disrupts glycolysis and blocks mTORC1 signaling
- •Production of 2-AMP-3PG by SidL occurs early during the Legionella infection cycle
Summary
The large effector arsenal of the bacterial pathogen Legionella pneumophila has been a rich source of biochemistry, highlighting the immense diversity of strategies deployed in host-pathogen conflict. Here, we redefine the purported translation inhibitor SidL as an adenylyltransferase that targets a glycolytic metabolite, discovering that it modifies 3-phosphoglycerate with adenosine monophosphate (AMP) to produce the previously unknown molecule 2-AMP-3-phosphoglycerate. When expressed alone in mammalian cells, SidL adenylates 3-phosphoglycerate, disrupts glycolysis, and blocks the nutrient-responsive translation regulator mTORC1, which we propose indirectly causes translation inhibition. Moreover, we observe SidL-dependent production of 2-AMP-3-phosphoglycerate in macrophages during L. pneumophila infection, the timing of which is consistent with a role for SidL in the early stages of the infection cycle. Thus, our study uncovers a mechanism by which an intracellular pathogen uses the chemical modification of a glycolytic intermediate to target central carbon metabolism in the host.
Read full article for free (open access):
https://www.sciencedirect.com/science/article/pii/S1097276526004715
- Get link
- X
- Other Apps